Robert K. Stuart, M.D.

Provider Image

4.9 out of 5 (138 ratings)

Returning Patients

843-792-9300 843-792-9300

Degree M.D.
School Johns Hopkins University School of Medicine
  • Johns Hopkins Hospital
  • Memorial Sloan - Kettering Cancer Center
  • Johns Hopkins Oncology Center
Board Certification
  • Internal Medicine
  • Internal Medicine: Hematology
  • Internal Medicine: Medical Oncology
  • Hematology/Oncology
  • Cancer - Blood & Lymphatic
Clinical Interests
  • Hematological malignancies
  • Acute leukemia
  • Lymphoma
  • Multiple myeloma
  • Bone marrow transplant (BMT)
Accepts New Patients No

Returning Patients

843-792-9300 843-792-9300


Hollings Cancer Center
86 Jonathan Lucas Street
Charleston, SC 29425
Map & Directions


Robert K. Stuart, M.D., is professor of medicine, Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.

A native of Baton Rouge, Louisiana, Dr. Stuart is a 1974 graduate of the Johns Hopkins University School of Medicine and undertook his internal medicine training at the Johns Hopkins Hospital. He completed a medical oncology fellowship at the Johns Hopkins Oncology Center and a research fellowship in the laboratory of developmental hematopoiesis at the Memorial Sloan Kettering Cancer Center before being appointed assistant professor of oncology and medicine at Johns Hopkins in 1979. As a member of the Johns Hopkins Oncology Center staff, he was an attending physician on the bone marrow transplant and acute leukemia services, and his laboratory research was funded by the American Cancer Society, the Leukemia Society of American and the National Cancer Institute. In 1984, he was promoted to associate professor of oncology and medicine at Johns Hopkins.

The following year Dr. Stuart was named professor of medicine and founding director of the Hematology/Oncology Division of the Medical University of South Carolina (MUSC) where he established an accredited hematology/oncology fellowship training program in 1986. He played a key role in the development of the Ernest F. Hollings Cancer Center, which he served as associate director for clinical trials. He also established a cancer clinical trials program, and MUSC became an affiliate member of the Cancer and Leukemia Group B (CALGB) associated with Wake Forest University. In 1995, MUSC became a main member of the CALGB with Dr. Stuart as its principal investigator. Currently MUSC is a main member of SWOG (formerly Southwest Oncology Group) and Dr. Stuart is its principal investigator.

In 1997, Dr. Stuart was named chairman of the Department of Oncology at the King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia, where he directed over 70 physicians from 19 countries. The Oncology Department, modeled after a North American comprehensive cancer center, was composed of six sections: medical oncology, radiation oncology, adult hematology/bone marrow transplantation, pediatric hematology/oncology, palliative care medicine, and the oncology data unit. In 2001, Dr. Stuart returned to MUSC as professor of medicine in the Hematology/Oncology Division, as director of the Hollings Cancer Center’s hematological malignancies program and the blood and marrow transplant (BMT) program, and as the medical director of the clinical trials office. 

Dr. Stuart is certified by the American Board of Internal Medicine in internal medicine, medical oncology, and hematology. He has authored or co-authored over 250 articles, abstracts, and book chapters in various areas of hematology, oncology and stem cell transplantation. He is a founding director of the Aplastic Anemia & MDS (Myelodysplastic Syndrome) International Foundation and is a member of numerous medical and scientific societies. He has received the American Society of Hematology’s Champions of Advocacy Award, the Leukemia & Lymphoma Society’s Partners in Progress Award, and the MUSC Foundation’s Outstanding Clinician Award and Distinguished Faculty Service Award. He has been elected by his peers for inclusion in Best Doctors in America since 1996. His  interests are clinical and translational studies of acute leukemia and other hematological malignancies, new drug development, hematopoietic stem cell transplantation, teaching, and clinical trials.